Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2010
09/23/2010US20100240642 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240636 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010US20100240618 Substituted piperazines
09/23/2010US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
09/23/2010US20100239788 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound
09/23/2010US20100239631 Thiopyrimidine-based compounds and uses thereof
09/23/2010US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
09/23/2010US20100239496 Imaging agents for detecting neurological disorders
09/23/2010US20100237339 Carbazole Derivative with Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative with Heteroaromatic Ring
09/23/2010CA2756003A1 Amide derivatives as neuropeptide y5 receptor ligands
09/23/2010CA2755697A1 Amide derivative
09/23/2010CA2755641A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2755251A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2749650A1 Piperidine derivatives as nk3 receptor antagonists
09/22/2010EP2229383A1 Isoxazolo-pyrazine derivatives
09/22/2010EP2229374A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors
09/22/2010EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/22/2010EP2229363A1 Renin inhibitors
09/22/2010EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
09/22/2010EP2134704B1 Compounds and compositions as modulators of gpr119 activity
09/22/2010EP2091950B1 Oxadiazole derivatives as s1p1 receptor agonists
09/22/2010EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
09/22/2010EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
09/22/2010EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010CN1863799B Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
09/22/2010CN1856484B Therapeutic agents useful for treating or preventing pain
09/22/2010CN101842371A 3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor
09/22/2010CN101842361A Pyrazinone derivatives and their use in the treatment of lung diseases
09/22/2010CN101842360A Anti-infective pyrimidines and uses thereof
09/22/2010CN101838271A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
09/22/2010CN101838263A Benzimidazole derivative with cardiovascular activity and preparing method and application thereof
09/21/2010US7799915 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799808 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
09/21/2010US7799796 Diaminopyrimidines as P2X3 and P2X2/3 modulators
09/21/2010US7799793 N-alkylated rifampin
09/21/2010US7799792 7-chloro-5-(5-piperazin-1-ylmethyl-[1,2,4]oxadiazol-3-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, for the treatment of nervous system disorders and psychological disorders
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799781 5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors
09/21/2010US7799779 5-[4-(3-Methoxypropyl)3.4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-4 -(4-phenoxyphenyl)-piperidin-3-ol, used for treating high blood pressure, glaucoma, myocardial infarction, restenoses or stroke
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010US7799576 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
09/21/2010CA2499429C Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
09/21/2010CA2444123C Novel arylsulfonamides as antiviral agents
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2411111C Thiazolyl, oxazolyl and pyrazolyl-substituted heterocycles and their use as pesticides and herbicides
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/16/2010WO2010104933A1 Inhibitors of akt activity
09/16/2010WO2010104194A1 Benzofuran derivatives
09/16/2010WO2010104193A2 Intermediate compound for synthesizing pharmaceutical agent and production method thereof
09/16/2010WO2010103335A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103333A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
09/16/2010WO2010102809A1 Substituted nicotinamides as kcnq2/3 modulators
09/16/2010WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor
09/16/2010WO2010059606A3 Inhibitors of diacylglycerol acyltransferase
09/16/2010WO2010059241A3 Treatment of amyotrophic lateral sclerosis
09/16/2010WO2010056320A3 Pi3k/mtor kinase inhibitors
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010WO2010039237A8 Compounds for inflammation and immune-related uses
09/16/2010US20100234599 Method for preparing acid addition salts of polyacidic basic compounds
09/16/2010US20100234594 Inhibitor of binding of s1p1
09/16/2010US20100234593 Imidazo[4,5-B]Pyridine-7-Carboxamides 704
09/16/2010US20100234591 Biaryl heterocyclic compounds and methods of making and using the same
09/16/2010US20100234404 P-38 Kinase Inhibitors
09/16/2010US20100234395 Ureide derivative and pharmaceutical application thereof
09/16/2010US20100234391 N-substituted piperazines
09/16/2010US20100234390 Novel compound and their use
09/16/2010US20100234389 Amide compound
09/16/2010US20100234380 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
09/16/2010US20100234378 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors
09/16/2010US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
09/16/2010US20100234376 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors
09/16/2010US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
09/16/2010US20100234373 Bis-aryl amide compounds and methods of use
09/16/2010US20100234372 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators
09/16/2010US20100234371 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof
09/16/2010US20100234369 5-cyanothienopyridines for the treatment of tumours
09/16/2010US20100234368 Condensed ring compound and use thereof
09/16/2010US20100234365 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/16/2010US20100234357 Benzofuran derivatives
09/16/2010US20100234355 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
09/16/2010US20100234354 Pyridazinone derivatives
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234346 Novel pyrimidine derivatives
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/16/2010US20100234324 Quinazolinamide derivatives
09/16/2010US20100234219 Isoxazolines for Controlling Invertebrate Pests
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 647